Your shopping cart is currently empty

LY3154207 is a subtype selective, potent, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $432 | 10-14 weeks | 10-14 weeks | |
| 25 mg | $1,430 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,860 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,690 | 10-14 weeks | 10-14 weeks |
| Description | LY3154207 is a subtype selective, potent, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM). |
| Targets&IC50 | D1 receptor (human):(EC50)3 nM |
| In vitro | In a study conducted on HEK293 cells transiently expressing D1 receptors from human, dog, rhesus monkey, and mouse, LY3154207 demonstrated EC50 values of 2.3 nM, 2.0 nM, 2.5 nM, and 62.1 nM, respectively[1]. |
| Molecular Weight | 450.4 |
| Formula | C24H29Cl2NO3 |
| Cas No. | 1638667-79-4 |
| Smiles | C[C@@H]1N([C@@H](CO)Cc2c(CCC(C)(C)O)cccc12)C(=O)Cc1c(Cl)cccc1Cl |
| Relative Density. | 1.245 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.